Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • FDA advisory committee recommends approval of lofexidine for opioid withdrawal symptoms

    by
    • Optum Workers' Comp
    | Apr 06, 2018
    Tag Icon
    Opioids, FDA
    An advisory committee of the U.S. Food and Drug Administration (FDA) voted to approve a non-opioid, lofexidine hydrochloride, to alleviate the symptoms of abrupt opioid withdrawal. Lofexidine, an alpha-2 adrenergic agonist that works by reducing the release of norepinephrine, is similar to clonidine, which has been used off-label for the management of opioid withdrawal symptoms. According to this report, lofexidine has been found to be safe and effective in reducing symptoms of nausea, vomiting, anxiety, diarrhea and the overall feeling of sickness during withdrawal. Lofexidine has been marketed in the United Kingdom (UK) as BritLofex since 1992 to relieve symptoms in patients undergoing opioid detoxification.


  • Kentucky workers’ compensation drug formulary bill signed

    by
    • Optum Workers' Comp
    | Apr 04, 2018
    Tag Icon
    Chronic Pain, Opioids, Formularies
    Kentucky House Bill 2, workers’ compensation reform legislation, was recently signed into law. The new law addresses several areas – including requiring the adoption of a drug formulary and additional medical treatment guidelines addressing chronic pain management and opioid use.


  • West Virginia enacts opioid prescribing restrictions

    by
    • Optum Workers' Comp
    | Apr 03, 2018
    Tag Icon
    Opioids
    On March 27, West Virginia’s governor signed into law Senate Bill 273, comprehensive legislation addressing opioid prescribing and related treatment. The most notable provisions in this bill establish opioid prescribing limits and prescriber requirements for initial, subsequent and ongoing treatment.


  • Indiana Workers’ Compensation Drug Formulary Bill Signed

    by
    • Optum Workers' Comp
    | Mar 28, 2018
    Tag Icon
    Formularies, formulary
    Indiana Senate Bill 369 was recently signed into law. This new law requires implementation of a workers’ compensation drug formulary based on the Official Disability Guidelines (ODG) Workers' Compensation Drug Formulary Appendix A, effective initially January 1, 2019.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.